💰 Femasys Advances Final Phase of FemBloc with FDA Approval & $12M Funding

FDA clears final trial stage for non-surgical birth control; $12M raised to support rollout with potential to reach $58M.

"This FDA IDE approval represents a critical milestone in advancing FemBloc toward U.S. approval, bringing women a long overdue, non-surgical option for permanent birth control."

— Kathy Lee-Sepsick, CEO & Founder, Femasys Inc.

🔗 Read More

‍

🏥 Kimberly-Clark Bets Big on Health with $40B Kenvue Deal‍

A bold move into consumer health with one of the year’s biggest acquisitions.

🔗 Read More

‍

🔬 LiviWell Raises $3.3M Seed for Diagnostic Device Launch‍

Funding will support FDA clearance and market entry for reproductive health tool.

"With this support, we're positioned to navigate the FDA clearance process and bring Livi to the women who need it most."

— Dawn Halkuff, CEO, LiviWell

🔗 Read More

‍

🌩️ Calm/Storm Ventures Launches €30M Healthtech Fund‍

New fund targets early-stage startups in digital health, femtech, and wellness.

🔗 Read More

‍

🧬 EIB Injects €20M into Overture Life to Scale IVF Automation‍

Backing AI and robotics to expand access to assisted reproduction.

🔗 Read More

‍

💰 Pluro Fertility Raises $14M to Expand IVF Platform‍

Series A funding will grow its tech-driven fertility care across emerging markets.

🔗 Read More

‍

Another big week! Let us know what you're working on, or who we should feature next.  

‍Email us at info@womenshealthweek.com and put "Scoop Request" as the subject!